+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
From
Condyloma - Pipeline Insight, 2025 - Product Thumbnail Image

Condyloma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nanomedicine Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Nanomedicine Market - Forecasts from 2023 to 2028

  • Report
  • September 2023
  • 146 Pages
  • Global
From
From
From
Gastrointestinal Diseases Therapeutics Market 2025-2029 - Product Thumbnail Image

Gastrointestinal Diseases Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 215 Pages
  • Global
From
From
Viral Hepatitis Market Report 2025 - Product Thumbnail Image

Viral Hepatitis Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Pharmaceutical Drug Delivery Market Report 2025 - Product Thumbnail Image

Pharmaceutical Drug Delivery Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Loading Indicator